3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Myelodysplastic Syndromes
5
Leukemia, Myeloid, Acute
5
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Leukemia, Myelomonocytic, Chronic
2
Leukemia
2
Hodgkin Disease
2
Graft vs Host Disease
2
Burkitt Lymphoma
2
Anemia, Refractory, with Excess of Blasts
2
Recurrence
1
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Biphenotypic, Acute
1
Hemoglobinopathies
1
Hematologic Neoplasms
1
Bone Marrow Failure Disorders
1
Advanced Urothelial Carcinoma
1
Interventions
Cytarabine
3
Injections
2
Idarubicin
2
Gemtuzumab
2
Filgrastim
2
Decitabine
2
veliparib
1
fludarabine phosphate
1
aldesleukin
1
Whole-Body Irradiation
1
Temozolomide
1
Peripheral Blood Stem Cell Transplantation
1
Granulocyte Colony-Stimulating Factor
1
Etoposide
1
Daunorubicin
1
CPX-351
1
Busulfan
1
Bone Marrow Transplantation
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelomonocytic, Acute
×
Clofarabine
×
1 year
×
Clear all
No trials found.